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A SEROLOGICAL STUDY OF CYSTICERCOSIS IN PATIENTS WITH HIV
Subhash Chandra PARIJA & A.R. GIREESH 
SUMMARY
Neurocysticercosis (NCC) has attained the importance of one of the most common cause of focal brain lesions in patients infected 
with HIV (human immunodeficiency virus). Adequate data regarding the rate of this co-infection is lacking. Therefore, the present 
study was carried out to determine the prevalence of cysticercosis among HIV patients residing in Puducherry or its neighboring 
districts of Tamil Nadu State, India. A total of one hundred blood samples were collected from HIV seropositive cases visiting JIPMER 
hospital, Puducherry, between June 2007 and May 2008. Enzyme immunotransfer blot (EITB) and enzyme linked immunosorbent 
assay (ELISA) were used to demonstrate anti- T. solium larval stage antibodies and Co-agglutination (Co-A) test was used to detect T. 
solium larval stage antigens in sera. Two HIV seropositive cases were found positive for anti-T. solium larval stage antibody by EITB 
and four were positive by ELISA. Only one sample was positive by both EITB and ELISA. No serum sample was found positive for 
T. solium larval stage antigen by Co-A test. The overall seropositivity detected by all the methods was 5% in this study group. The 
accurate clinical diagnosis of NCC in HIV is difficult due to deranged immunological parameters in the HIV infected patients. The 
results of this study provides important data on the prevalence of cysticercosis in HIV positive patients in Puducherry and neighboring 
areas which was previously unknown. This study will also increase awareness among physicians and public health agencies about T. 
solium cysticercosis in the selected group. 
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INTRODUCTION
Cysticercosis, a disease caused by the larval stage of cestode parasite 
Taenia solium is widely prevalent in human and porcine hosts in many 
developing countries of Latin America, Africa and Asia7. Approximately 
50 million people are infected with T. solium and about 50,000 deaths 
occur due to this disease worldwide every year4. Human cysticercosis 
results from the ingestion of food, water and vegetables contaminated 
with T. solium eggs or even by autoinfection in case of persons with 
intestinal taeniasis. The central nervous system (CNS) is the most 
common site of severe symptomatic infection where the condition is 
referred to as NCC23.
Due to the increased frequency of HIV infection, cysticercosis has 
become one of the most frequent opportunistic infections and the most 
common cause of focal brain lesions in patients infected with HIV10,11. 
Furthermore, cysticercosis is endemic in many regions of the world and 
more common in pig eating countries with low socioeconomic status 
and poor sanitation3. HIV infection is a serious problem in the present 
day world wide. A high rate of infection is found in many regions of 
the world, including India17. One of the major health problems among 
HIV seropositive patients is superimposed infections due to the defect 
in immunity15. The increasing frequency of HIV infection in endemic 
areas of cysticercosis may increase this co-infection. Only few cases 
of cysticercosis in HIV - infected patients have been reported, and 
the influence of HIV infection on the natural history of cysticercosis 
is yet to be defined. We therefore conducted this study specifically to 
determine the seroprevalence of cysticercosis in HIV seropositive cases 
residing in Puducherry or its neighboring districts of Tamil Nadu State 
for specific T. solium larval stage antigens and anti-T. solium larval stage 
antibodies using immunological techniques developed and evaluated in 
this laboratory.
MATERIALS AND METHODS
Study group: A total of one hundred serum samples from HIV 
seropositive cases were analyzed. This study was carried out in the Out 
Patient Department and Inpatient wards of Medicine and Neurology in 
Jawaharlal Institute of Postgraduate Medical Education and Research 
(JIPMER) hospital, Puducherry, India. Serum samples collected from 
the patients were screened for antibodies against HIV by ELISA and 
confirmed by Western blot. 
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Controls: Sera collected from known positive NCC cases (confirmed 
by MRI, EITB and ELISA) were used as positive control (n = 16 definitive 
diagnosis group, as per the diagnostic criteria for the diagnosis of NCC 
by DEL BRUTTO et al. in 2001)7. For negative control, sera collected 
from normal healthy individuals were used (n = 25). Sera collected from 
patients with hydatidosis were used to detect the cross reactivity (n = 
15). For Co-A test, 10 μL of total soluble protein antigen of T. solium 
larval stage was added to 90 μL of phosphate buffered saline (PBS) pH 
7.2 (1:10) which was further diluted to 1:1280 using PBS pH 7.2. This 
was taken as positive control. Informed consent was obtained from all 
subjects in this group.
Preparation of the T. solium larval stage antigens: The T. 
solium larval stage was collected from the tissue of naturally infected 
pig, which were dissected free from surrounding tissue into sterile 
PBS pH 7.2 containing 40 mg each of kanamycin, nalidixic acid and 
ampicillin with protease inhibitor, phenylmethylsulphonyl fluoride 
(PMSF) (0.006%) at room temperature. Whole cysts after removing 
the cyst fluid were taken to prepare the complete somatic homogenate 
antigen as per the method described by SREENIVASAMURTHY et 
al., 199927. Ten grams of ruptured whole cysts were homogenized 
manually in glass tissue homogenizer with PBS (pH 7.2) containing 
PMSF (0.1 mM) at 4 0C. The homogenate was further subjected to 
sonication, eight times at 12kHz with 30 seconds cooling interval on 
an ice bath. The homogenate was centrifuged at 4 0C for 30 minutes 
at 15,000 rpm in refrigerated centrifuge. The supernatant was used as 
the T. solium larval stage somatic antigen27. The protein analysis of 
complete somatic homogenate was carried out by standard procedure 
described by LOWRY et al., 195116. 
ANTIBODY DETECTION 
Sodium dodecyl sulfate-polyacrylamide gel electrophoresis 
(SDS-PAGE): SDS-PAGE was indicated for analyzing the protein 
profile of the antigen, by characterizing & separating proteins based on 
their molecular weight. Briefly, the metacestode antigen was subjected 
to SDS-PAGE in 10% gel for resolving the antigenic peptides using a 
submerged gel electrophoresis apparatus (Bangalore Genei, India) using 
standard protocol24. The antigen preparations were separated under 
non-reducing conditions by sodium dodecyl sulfate-polyacrylamide 
gel electrophoresis gradient gels on 10 X 8 cm (1-mm thick) mini-gels 
(Bangalore Genei, India). The gels were stained with Coomassie Brilliant 
Blue and molecular weight was determined using standard molecular 
weight markers (Bangalore Genei, India)30.
Enzyme immuno transfer blot: The glycoprotein antigen used 
in EITB was prepared by using metacestodes obtained from naturally 
infected pig to analyze the antibody response. For immunoblotting 
analysis, the separated antigens mentioned above were electrophoretically 
transferred to a 0.22-μm-pore-size nitrocellulose membrane (NCM) 
(Pierce, Rockford) in a mini-Transblot cell (Pharmacia Biotech, USA). 
The free binding sites were blocked by treatment with 3% bovine serum 
albumin (BSA) in PBS for two h and washed in PBS containing 0.1% 
Tween 20. Analysis was carried out with human sera diluted 1:100 
in PBS (pH 7.2) containing 0.1% Tween 20 (PBST)30. Horseradish 
peroxidase-conjugated goat antibody to human IgG diluted 1:1000 
(Bangalore Genei), was used as secondary antibody. Antibody reactivity 
was visualized with a substrate solution containing diaminobenzidine 
(Pierce, Perbio) (6 mg/mL in PBS containing one mL of 30% hydrogen 
peroxide (Sigma)2. 
Enzyme linked immunosorbent assay: ELISA was performed 
as per the procedure described by standard method of Crowther with 
few modifications6. Briefly, one μg protein per 100 μL concentration 
of the antigen was prepared in antigen coating buffer (PBS pH 7.2) as 
per the method described earlier and used for coating plates (NUNC) 
followed by blocking non-specific binding sites by 2% BSA in PBS 
(pH 7.2). Optimum dilution (1:50) of test serum sample and known T. 
solium larval stage antibody-positive serum samples were prepared in 
sample dilution buffer, added in duplicate in the wells, and goat anti-
human-IgG-HRP conjugated secondary antibody (Bangalore Genei, 
India) was added to each well for detection. Substrate solution prepared 
freshly by adding six mg of OPD in 10 mL of PBS pH 7.2 and 10 μL 
of H2O2 (30%) was added just before to use. The reaction was stopped 
by adding 50 μL of 2N H2SO4 in each well to avoid over reaction and 
development of optimum colour9. The absorbance was taken at 492 
nm in an ELISA reader (BIO RAD). Various controls were used for 
validity of the assay such as antigen blank, antibody blank, negative 
control serum, and known positive control serum. Serum sample which 
gave OD492 value of more than cut-off (mean of 50 negative serum 
samples + 2 SD) was considered as positive. The cut-off used in the 
present study was 0.157.
ANTIGEN DETECTION 
Co-agglutination test: Co-A test to detect T. solium larval stage 
antigen in the serum was carried out as per the method described 
by us before20. In this test Cowan’s strain of Staphylococcus aureus 
rich in Protein A (SAPA) cells, sensitized with polyclonal antibodies 
(hyperimmune serum against T. solium larval stage) were used to detect 
specific T. solium larval stage antigen in the serum. The hyperimmune 
serum was used at the concentration of 100 μL/10 mL of SAPA cells 
suspension (1%) as the optimal sensitizing dose (OSD). Hyperimmune 
serum against T. solium larval stage whole cyst antigen (total soluble 
protein antigen) was raised in white New Zealand rabbit in divided doses 
with Freund’s complete adjuvant in the primary dose and with incomplete 
adjuvant in the booster doses. The IgG fraction from the immune serum 
was purified by precipitation with cold saturated ammonium sulphate 
by the method of GOTTSTEIN14. 
The test was performed as per the procedure described by SHARIFF 
& PARIJA (1993)26. Sensitization of these cells was done by adding 0.1 
mL of rabbit antisera to one mL of 10% Staphylococcal suspension and 
incubated for 30 minutes at 37 0C in water bath. These incubated cells 
were washed in PBS and re-suspended to a concentration of 2% in PBS 
7.2 with 0.1% sodium azide. The test was performed on glass slides, 
which were divided with a glass marking pencil into two equal halves. 
25 μL of the test serum sample was placed on each half of the slide. An 
equal volume (25 μL) of sensitized SAPA cell suspension was added to 
the serum on one half. The same volume (25 μL) of a 2% suspension 
of unsensitized SAPA cells was added to the serum on the half as a 
cell control. The slide was then rotated manually for two min and then 
observed. In a positive Co-A test, the addition of sensitized SAPA cells 
to the test serum resulted in the formation of large visible clumps of 
bacterial cells within two min; in a negative reaction, no visible clumping 
was observed. Agglutination with the sensitized cells and not with the 
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unsensitized cells was considered to be a positive result. It is a qualitative 
test, so there is no cut-off used.
RESULTS
SDS PAGE & enzyme immunotransfer blot: In the present study 
the high molecular weight antigenic peptides were observed to be reactive 
and specific to patient sera more frequently than the low molecular weight 
antigenic peptides when T. solium larval stage somatic antigens were used. 
A total of six major bands were detected in the T. solium larval stage 
antigen in the SDS-PAGE profile. The major antigenic peptides were 
found to be 100kDa, 75kDa, 67.74kDa, 51.6kDa, 47kDa, 43.5kDa. Only 
two antigenic peptides, i.e. the 75kDa, 67.74kDa, were demonstrated by 
the EITB in serum samples. Of 100 serum samples tested, two (2%) had 
anti-T. solium larval stage antibodies. The antibody to T. solium larval 
stage somatic antigen reacting with one or more of these peptides in the 
serum was considered positive by the test. 
Enzyme linked immunosorbent assay: ELISA demonstrated 
reactive T. solium larval stage antibody titre in four (4%) serum samples 
collected from HIV seropositive cases. The cut-off OD492 values of the 
ELISA using T. solium larval stage somatic antigen was used to detect 
IgG antibodies in the serum. The test detected antibodies in sera from 
known positive controls and did not show any antibodies in the sera of 
negative controls and patients with hydatid disease. 
Co-agglutination test: The Co-A detected T. solium larval stage 
antigen in none of the serum samples out of total 100 HIV seropositive 
cases. The results were compared with that of EITB for detection of 
antibodies. Among these samples two (2%) were positive for anti-T. 
solium larval stage antibody by EITB and four (4%) were positive for 
antibodies by ELISA. Only one sample was found positive in both tests 
indicative of a low concordance between the two assays. Thus, overall 
five samples were positive for anti-T. solium larval stage antibodies. 
The antigen detection limit of the Co-A test using the particular batch 
of reagent preparation was found to be up to 0.27 μg21.
DISCUSSION
Relatively few cases of HIV and NCC co-infection have been 
reported, even in areas where there is high prevalence of both diseases 
individually5,25,28,29. In a study conducted in Mexico only 1.1% of NCC 
has been reported in HIV positive cases, compared with 2.4% in control 
autopsies15. In South Africa, co-infections by HIV, M. tuberculosis, and 
T. solium are relatively common in densely populated area where the 
parasite is widely distributed18. NCC has been reported in HIV cases 
traveling to areas with high intensity of cysticercosis29. In this report 
HIV test serology was positive by ELISA and Western blot and the CD4+ 
T-lymphocyte count was 473 cells/μL. SERPA et al. (2007) reported 
NCC as a fatal infection in a HIV infected Colombian immigrant at 
Spain10. An unusual form of epidural spinal racemose NCC revealed 
by compression of Cauda equina in a HIV infected man was reported 
in France. SERPA et al. (2007)25 identified 27 cases of NCC-HIV co-
infection in Houston. The most frequent presentation (61%) was with 
multiple parenchymal lesions8. Similarly, NCC and HIV co-infection 
are reported from different areas of the world including, Italy, Ecuador, 
Mexico and Zimbabwe10,11,25,28,29. However, little is known about the 
association of HIV and the clinical course of cysticercosis. Concurrent 
infection with T. solium and HIV would be expected to occur more 
frequently because of the increasing frequency of HIV infection in India 
where cysticercosis is endemic. 
In the present study EITB and ELISA were used to detect anti-T. 
solium larval stage antibody in patients with HIV. In most of the 
studies sensitivity and specificity of EITB reported was 98% and 100% 
respectively1,3,13. Many of the investigators have found a varying sensitivity 
and specificity with ELISA test for detection of anti-T. solium larval stage 
antibody, using different antigenic preparations19.. However, ELISA and 
EITB are the most frequently used tests in recent times. By using EITB 
and ELISA, 5% serum samples were positive for anti-T. solium larval 
stage antibody in HIV cases. The anti-T. solium larval stage antibody 
positive cases were from Villupuram, Cuddalore, Thiruvannamalai 
districts that are immediately neighboring to Puducherry where pig 
farming is commonly done. 
Among the anti-T. solium larval stage antibody positive cases, 
none of them were presenting the symptoms of NCC or other form of 
cysticercosis. The presence of anti-T. solium larval stage antibodies in 
five cases indicates that the cases either have suffered from cysticercosis 
in past or having an infection with no overt clinical manifestations. In 
this study the seroprevalence of cysticercosis was less in HIV patients 
compared to non HIV infected individuals (6.1%)22. This apparently 
lower prevalence in this population may be due to absent or low immune 
response in patients with HIV or the cystic stages of the parasite may 
not evoke a strong detectable antibody response while they remain alive 
and intact. 
T. solium larval stage antigen was detected by Co-A test in 57% of 
cysticercosis cases with hyperimmune sera raised to whole cyst antigen 
in the previous studies20,21,22. An interesting finding was that none of the 
HIV seropositive cases were positive for T. solium larval stage antigen. 
The failure of Co-A in these cases to detect antigen could be either due 
to the absence of antigen in the serum, or antigen concentration that were 
below detection limit of the assay or as a result of degradation of antigen 
during storage of the serum at -20 0C. 
Diagnosis of cysticercosis in HIV patients is very important, because 
tuberculous meningitis and toxoplasmosis are very common in this group 
which mimics NCC32. So a consideration of cysticercosis in this group 
of patients can help in early diagnosis. Detection of the antibodies in the 
serum to T. solium larval stage antigens is the most commonly used and 
convenient method for the laboratory diagnosis of cysticercosis31. As the 
immune response is lowered in HIV positive patients the sensitivity of 
antibody detection may be reduced in this group of patients. Symptomatic 
cysticercosis largely depends on the host inflammatory response33. 
Decreased cell-mediated immunity characteristic of advanced HIV 
infection makes cysticercosis more likely to remain asymptomatic31, 32. 
In sero-diagnosis the initially reported high sensitivity and specificity of 
the EITB assay may be ambiguous to detect antibody in this study group. 
So the result of EITB assay may be more reliable in patients with AIDS, 
in combination with radiographic and clinical data. 
CONCLUSION
This study provides important data on the sero-prevalence of T. solium 
cysticercosis in HIV positive patients in Puducherry and neighboring 
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areas which was previously unknown. This population is at risk for T. 
solium cysticercosis where the parasite affects the immune response of the 
host. We hope this study will increase awareness among physicians and 
public health agencies about T. solium cysticercosis in the selected group. 
As the incidence of HIV is increasing in endemic areas of cysticercosis, 
simultaneous diagnosis of both diseases is an event to be expected. 
RESUMO
Estudo sorológico da cisticercose em pacientes com HIV
Neurocisticercose (NCC) tem alcançado a importância de uma das 
mais comuns causas de lesões focais no cérebro em pacientes infectados 
pelo HIV (vírus da imunodeficiência adquirida). Dados adequados 
relativos à frequencia desta co-infecção estão faltando. Portanto, o 
presente estudo foi realizado para determinar a prevalência da cisticercose 
entre pacientes com HIV residindo em Puducherry ou distritos vizinhos 
do Estado de Tamil Nadu, India. Um total de cem amostras foram 
coletadas de casos soropositivos do Hospital JIPMER, Puducherry, 
entre junho de 2007 e maio de 2008. “Enzyme immunotransfer blot” 
(EITB) e ELISA foram utilizados para demonstrar anticorpos contra a 
fase larval do T. solium. Testes de co-aglutinação (Co-a) foram usados 
para demonstrar antígenos da fase larval do T. solium no soro. Dois casos 
HIV soropositivos foram positivos para anticorpos contra a fase larval do 
T. solium por EITB e quatro foram positivos por ELISA. Somente uma 
amostra foi positiva por ambos EITB e ELISA. Nenhuma amostra de soro 
foi positiva para antígeno da fase larval do T. solium pelo teste Co-a. A 
soropositividade total detectada por todos os métodos foi 5% neste grupo 
de estudo. O diagnóstico clínico exato de NCC em HIV é difícil devido 
aos desordenados parâmetros imunológicos nos pacientes infectados 
pelo HIV. Os resultados deste estudo fornecem dados importantes sobre 
a prevalência da cisticercose em pacientes HIV positivos em Puducherry e 
áreas vizinhas que eram previamente desconhecidos. Este estudo também 
aumentará a atenção dos médicos e agências de saúde pública sobre a 
cisticercose por T. solium em grupo selecionado.
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